{'fraction_non_alphanumeric': 0.027586206896551724, 'fraction_numerical': 0.005517241379310344, 'mean_word_length': 5.148305084745763, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Changes in opioid receptor binding nature in rat brain and spinal cord following formalin or carrageenan-induced nociception].

Previous reports demonstrated the regulation of opioid and their receptor in nociception, but it is not clear how nociceptive activation may alter opioid receptor binding nature. We determined the change of mu, delta and kappa opioid receptor types in brain and spinal cord homogenates obtained from animal models receiving nociceptive treatment. 1) Rats received a subcutaneous injection of formalin and carrageenan into planter aspect of a hindpaw. These agent-injected animals were observed for appearance of pain-related behavior (guarding of the treated paw) within 2-3 hour after treatment. Following these pain behavior, rats were decapitated and brain and spinal cord were removed rapidly. 2) The binding of 3H-DAGO (mu agonist), 3H-DPDPE (delta agonist) and 3H-EKC (kappa agonist) to brain and spinal cord membranes prepared from nociceptive treatment and control rats was determined. Using these tracer 3H-opioid ligands, we failed to see any change in the total number of opioid binding sites (Bmax values) or the affinity constant (Kd values) for binding in whole brain and spinal cord. These results indicate that in these animal models which use experimentally induced inflammation to stimulate a condition of nociception, there appears to be no alteration in the levels of mu, delta or kappa binding sites.